Status: Not yet recruiting
Apixaban Versus Enoxaparin for Postpartum Venous Thromboembolism Prophylaxis
The purpose of this study is to compare the use of oral apixaban to subcutaneous enoxaparin for venous thromboembolism (VTE) prophylaxis in postpartum women at high risk for VTE. The primary goal is to evaluate medication adherence rates and patient satisfaction with the treatment.
Participants needed: 150
Trial details
Age: 18+Biological sex: FemaleType: InterventionalSponsor: Ron Beloosesky MDUpdated: Jul 21, 2026
Eligibility criteria
Age ≥ 18 years. [+3]
Breast feeding. [+12]